DECEMBER - 20226Managing EditorAlex D'souzaVisualizerChris LynnMichael WayneDecember - 16 - 2022, volume 06 - Issue 30 (ISSN 2691-4093) Published by ValleyMedia, Inc. Emailsales@medicaltechoutlook.comeditor@medicaltechoutlook.commarketing@medicaltechoutlook.comTo subscribe to Medical Tech OutlookVisit www.medicaltechoutlook.com Copyright © 2022 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffAlex D'souzaManaging Editoreditor@medicaltechoutlook.comDiabetes is a major health concern around the world. According to the American Presidency Project, over the last 20 years, diabetes has increased in prevalence and is the seventh leading cause of death in the U.S. As per World Health Organization, 442 million adults are living with diabetes, and by 2030, it will reach up to 520 million people. Besides adults, children are also at risk of type 1 and type 2 diabetes. With decades of research and technological advances, the medical field has made significant advances in the field of endocrinology. The technology has advanced from insulin pumps to insulin pens and to smartphone apps to monitor blood sugar levels. In response to the growing importance of diabetes awareness, diabetes solution providers have developed smart insulin, bioartificial pancreas, intestinal microbiota, and much more.With technological breakthroughs, the MedTech industry is striving to develop novel diabetes treatments. Cell therapy, for instance, is one of the potential cures for diabetes. It replaces malfunctioning insulin-producing cells and helps promote normal insulin production. The development of algorithms that calculate insulin requirements for a specific patient in real-time and the development of tiny glucose monitors placed under eyelids are some of the future trends.By 2026, the global diabetes drug market will reach 68 billion dollars, which will contribute to the discovery of revolutionary diabetes solutions. Researchers are developing microchips that could diagnose diabetes before symptoms appear, as well as nanorobots that travel through the bloodstream to measure glucose and deliver insulin. With the ever-increasing prevalence of diabetes, companies are continuously developing and deploying technologies to strengthen the healthcare sector and bridge the gap in care.In this edition, we aim to provide readers with insights into the current diabetes care solution space.Let us know your thoughts.Flattening the Diabetes Curve with TechnologyEDITORIALEditorial StaffJoe PhilipLaura PintoJoshua ParkerMerlin WatsonSarah FernandesGina ClumskyYenny TurnerTiffany Hayworth
< Page 5 | Page 7 >